These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 34301318)

  • 21. Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.
    Dhanjal DS; Singh R; Sharma V; Nepovimova E; Adam V; Kuca K; Chopra C
    Curr Med Chem; 2024; 31(13):1646-1690. PubMed ID: 37138422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender Differences in Global but Not Targeted Demethylation in iPSC Reprogramming.
    Milagre I; Stubbs TM; King MR; Spindel J; Santos F; Krueger F; Bachman M; Segonds-Pichon A; Balasubramanian S; Andrews SR; Dean W; Reik W
    Cell Rep; 2017 Jan; 18(5):1079-1089. PubMed ID: 28147265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Roles of small molecules in somatic cell reprogramming.
    Su JB; Pei DQ; Qin BM
    Acta Pharmacol Sin; 2013 Jun; 34(6):719-24. PubMed ID: 23728722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Induced pluripotent stem cells: a new paradigm to study human tissues].
    Sansac C; Assou S; Bouckenheimer J; Lemaître JM; De Vos J
    Biol Aujourdhui; 2016; 210(1):1-8. PubMed ID: 27286575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor-mediated reprogramming toward hematopoietic stem cells.
    Ebina W; Rossi DJ
    EMBO J; 2015 Mar; 34(6):694-709. PubMed ID: 25712209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicine.
    Asuelime GE; Shi Y
    J Mol Cell Biol; 2012 Aug; 4(4):190-6. PubMed ID: 22371436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.
    Ron-Bigger S; Bar-Nur O; Isaac S; Bocker M; Lyko F; Eden A
    Stem Cells; 2010 Aug; 28(8):1349-54. PubMed ID: 20572015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In Vivo Cellular Reprogramming: The Next Generation.
    Srivastava D; DeWitt N
    Cell; 2016 Sep; 166(6):1386-1396. PubMed ID: 27610565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fast chemical reprogramming system promotes cell identity transition through a diapause-like state.
    Chen X; Lu Y; Wang L; Ma X; Pu J; Lin L; Deng Q; Li Y; Wang W; Jin Y; Hu Z; Zhou Z; Chen G; Jiang L; Wang H; Zhao X; He X; Fu J; Russ HA; Li W; Zhu S
    Nat Cell Biol; 2023 Aug; 25(8):1146-1156. PubMed ID: 37550515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erase and Rewind: Epigenetic Conversion of Cell Fate.
    Pennarossa G; Zenobi A; Gandolfi CE; Manzoni EF; Gandolfi F; Brevini TA
    Stem Cell Rev Rep; 2016 Apr; 12(2):163-70. PubMed ID: 26589198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age reprogramming: cell rejuvenation by partial reprogramming.
    Singh PB; Zhakupova A
    Development; 2022 Nov; 149(22):. PubMed ID: 36383700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain.
    López-León M; Outeiro TF; Goya RG
    Ageing Res Rev; 2017 Nov; 40():168-181. PubMed ID: 28903069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of cellular rejuvenation.
    Denoth-Lippuner A; Jessberger S
    FEBS Lett; 2019 Dec; 593(23):3381-3392. PubMed ID: 31197818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.
    Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR
    Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.
    Horisawa K; Suzuki A
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(4):131-158. PubMed ID: 32281550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rejuvenation by Partial Reprogramming of the Epigenome.
    Mendelsohn AR; Larrick JW; Lei JL
    Rejuvenation Res; 2017 Apr; 20(2):146-150. PubMed ID: 28314379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.
    Firas J; Liu X; Lim SM; Polo JM
    Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular reprogramming to reset epigenetic signatures.
    Hewitt KJ; Garlick JA
    Mol Aspects Med; 2013; 34(4):841-8. PubMed ID: 22982217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of DNA demethylation by the XPC DNA repair complex in somatic and pluripotent stem cells.
    Ho JJ; Cattoglio C; McSwiggen DT; Tjian R; Fong YW
    Genes Dev; 2017 Apr; 31(8):830-844. PubMed ID: 28512237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic regulation of NANOG by miR-302 cluster-MBD2 completes induced pluripotent stem cell reprogramming.
    Lee MR; Prasain N; Chae HD; Kim YJ; Mantel C; Yoder MC; Broxmeyer HE
    Stem Cells; 2013 Apr; 31(4):666-81. PubMed ID: 23255147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.